These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 2472016)

  • 21. Abrupt versus gradual withdrawal of vitamin K antagonist treatment in patients with venous thromboembolic disease: assessment of hypercoagulability and clinical outcome.
    de Groot MR; Njo TL; van Marwijk Kooy M; Büller HR
    Clin Lab; 2000; 46(11-12):575-81. PubMed ID: 11109505
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prophylaxis of postoperative thromboembolic disease: heparinate or heparinoid? 1000 cases].
    Malavaud A; Bichain N; Nicolas D; Sethian M
    Anesth Analg (Paris); 1970; 27(2):225-35. PubMed ID: 4192784
    [No Abstract]   [Full Text] [Related]  

  • 23. Acenocoumarol-induced leukocytoclastic vasculitis.
    Jiménez-Gonzalo FJ; Medina-Pérez M; Marín-Martín J
    Haematologica; 1999 May; 84(5):462-3. PubMed ID: 10329927
    [No Abstract]   [Full Text] [Related]  

  • 24. Molecular weight determines the frequency of delayed type hypersensitivity reactions to heparin and synthetic oligosaccharides.
    Ludwig RJ; Schindewolf M; Alban S; Kaufmann R; Lindhoff-Last E; Boehncke WH
    Thromb Haemost; 2005 Dec; 94(6):1265-9. PubMed ID: 16411404
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hypocoagulation caused by thiabendazole-acenocoumarol interaction].
    Henri P; Mosquet B; Hurault de Ligny B; Lacotte J; Cardinau E; Moulin M; Ryckelinck JP
    Therapie; 1993; 48(5):500-1. PubMed ID: 8146845
    [No Abstract]   [Full Text] [Related]  

  • 26. [The topical use of heparinoid substances].
    BELLIBONI N
    Hospital (Rio J); 1963 Apr; 63():911-8. PubMed ID: 13970499
    [No Abstract]   [Full Text] [Related]  

  • 27. [STUDIES ON THE CUTANEOUS RESORPTION OF A HEPARINOID].
    MATHIES H; SCHNETTER H; ZINN D
    Arzneimittelforschung; 1964 Apr; 14():286-8. PubMed ID: 14238572
    [No Abstract]   [Full Text] [Related]  

  • 28. Laryngeal dyspnea in relation to an interaction between acenocoumarol and topical econazole lotion.
    Wey PF; Petitjeans F; Lions C; Ould-Ahmed M; Escarment J
    Am J Geriatr Pharmacother; 2008 Aug; 6(3):173-7. PubMed ID: 18775393
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Warfarin or acenocoumarol: which is better in the management of oral anticoagulants?
    Barcellona D; Vannini ML; Fenu L; Balestrieri C; Marongiu F
    Thromb Haemost; 1998 Dec; 80(6):899-902. PubMed ID: 9869157
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Ileus with the use of acenocoumarol].
    Logman WG
    Ned Tijdschr Geneeskd; 1967 Jun; 111(23):1056. PubMed ID: 6044083
    [No Abstract]   [Full Text] [Related]  

  • 31. [Ileus caused by the use of acenocoumarol].
    de Boer HH
    Ned Tijdschr Geneeskd; 1967 Apr; 111(15):675-8. PubMed ID: 6047044
    [No Abstract]   [Full Text] [Related]  

  • 32. [Acute dyspnea and maculo-papular eruption after taking acenocoumarol (Sintrom].
    Kamm W; Berger JP
    Rev Med Suisse Romande; 1998 Jun; 118(6):565-8. PubMed ID: 9689868
    [No Abstract]   [Full Text] [Related]  

  • 33. Oral lichen planus: clinical and histological evaluation in an open trial using a low molecular weight heparinoid (sulodexide).
    Femiano F; Scully C
    Int J Dermatol; 2006 Aug; 45(8):986-9. PubMed ID: 16911394
    [No Abstract]   [Full Text] [Related]  

  • 34. Acenocoumarol-induced Henoch-Schönlein purpura.
    Borrás-Blasco J; Girona E; Navarro-Ruiz A; Matarredona J; Giménez ME; Gutiérrez A; Enriquez R; Martinez A
    Ann Pharmacother; 2004 Feb; 38(2):261-4. PubMed ID: 14742763
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The potentiation of the heparin effect by heparinoids. 4. On the action mechanism of heparinoids].
    Pulver R
    Arzneimittelforschung; 1965 Nov; 15(11):1320-3. PubMed ID: 4166203
    [No Abstract]   [Full Text] [Related]  

  • 36. [Hemoptysis under acenocoumarol: role of the arrest of enzymatic inductor (carbamazepine)].
    Rivière I; Barjhoux C; Mallaret M
    Therapie; 1994; 49(2):142-3. PubMed ID: 7817339
    [No Abstract]   [Full Text] [Related]  

  • 37. Upper airway obstruction by sublingual hematoma: a complication of anticoagulation therapy with acenocoumarol.
    González-García R; Schoendorff G; Muñoz-Guerra MF; Rodríguez-Campo FJ; Naval-Gías L; Sastre-Pérez J
    Am J Otolaryngol; 2006; 27(2):129-32. PubMed ID: 16500477
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Heparinoid (author's transl)].
    Shiba T; Igarashi M
    Rinsho Ketsueki; 1981 Jul; 22(7):1037-43. PubMed ID: 6173500
    [No Abstract]   [Full Text] [Related]  

  • 39. Delayed-type hypersensitivity skin reactions due to heparins and heparinoids. Tolerance of recombinant hirudins and of the new synthetic anticoagulant fondaparinux.
    Koch P
    Contact Dermatitis; 2003 Dec; 49(6):276-80. PubMed ID: 15025697
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk of major bleeding during concomitant use of antibiotic drugs and coumarin anticoagulants.
    Penning-van Beest FJ; Koerselman J; Herings RM
    J Thromb Haemost; 2008 Feb; 6(2):284-90. PubMed ID: 18031295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.